| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratories of Microbiology and Tumor Transplantation, The Children's Cancer Research Foundation, and Department of Pathology, Harvard Medical School, at The Children's Hospital, Boston, Massachusetts; The Child Research Center of Michigan, Detroit, Michigan (C. S. S.); and The Department of Cell Biology, Albert Einstein Medical College, New York, New York (H. E.)
Ten sublines of the KB cell line obtained from a number of different laboratories were reexamined with respect to chromosome number and heterotransplantability to the Syrian hamster cheek pouch. Twelve clonal cultures derived from 2 of these sublines were similarly examined.
These sublines differed from one another and from the KB cell line originally studied, which was heterotransplantable with inocula of circa 10 cells. Only 2 of the sublines could be heterotransplanted with inocula of less than 104 cells; 6 were heterotransplantable with inocula of 104-106 cells; and 2 failed to heterotransplant, even with inocula of 106 cells. Similar differences in heterotransplantability were observed among the clonal derivatives of 2 of these sublines. Although the modal numbers of these sublines and clonal derivatives were basically similar, ranging from 73 to 80, a few lines had a chromosome of sufficiently distinctive morphology to serve as a marker. There was, however, no apparent correlation between these minor karyotypic differences and heterotransplantability. Possible differences between nonheterotransplantable and heterotransplantable sublines with respect to the pattern of variability in cytoplasmic protein and cytoplasmic ribonucleic acid (RNA) content per cell remain to be studied in detail.
1 These studies were supported in part by research grants C-6516, CA-02947, and E-4153 from the National Cancer Institute and the National Institute for Allergy and Infectious Diseases, NIH, USPHS, to The Children's Cancer Research Foundation, The Child Research Center of Michigan, and Albert Einstein Medical College, respectively.
2 Holds Research Career Award 1-K6-CA-22,150 from the National Cancer Institute.
3 Special Fellow 1-F3-CA-21,216-01, National Cancer Institute; present address: Morristown Memorial Hospital, Morristown, N. J.
Received 12/ 3/64.
Revised 4/28/65.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |